A better prediction of progression‐free survival in diffuse large B‐cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV(max)

In the era of rituximab, the International Prognostic Index (IPI) has been inefficient in initial risk stratification for patients with R‐CHOP‐treated diffuse large B‐cell lymphoma (DLBCL). To estimate the predictive values of PET/CT quantitative parameters and three prognostic models consisting of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi‐Yang, Song, Le, Zhao, Mei‐Xin, Hu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718622/
https://www.ncbi.nlm.nih.gov/pubmed/31343111
http://dx.doi.org/10.1002/cam4.2284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718622/
https://www.ncbi.nlm.nih.gov/pubmed/31343111
http://dx.doi.org/10.1002/cam4.2284

Ejemplares similares